SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Background

Qatar experienced a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual worker (CMW) population, who comprise 60% of the total population. This study aimed to assess ever and/or current infection prevalence in this population.

Methods

A cross-sectional population-based survey was conducted during July 26 to September 09, 2020, to assess both anti-SARS-CoV-2 positivity through serological testing and current infection positivity through polymerase chain reaction (PCR) testing. Associations with antibody and PCR positivity were identified through regression analyses.

Results

The study included 2641 participants, 69.3% of whom were <40 years of age. Anti-SARS-CoV-2 positivity was 55.3% (95% CI, 53.3%–57.3%) and was significantly associated with nationality, geographic location, educational attainment, occupation, and previous infection diagnosis. PCR positivity was 11.3% (95% CI, 9.9%–12.8%) and was significantly associated with nationality, geographic location, occupation, contact with an infected person, and reporting 2 or more symptoms. Infection positivity (antibody and/or PCR positive) was 60.6% (95% CI, 58.6%–62.5%). The proportion of antibody-positive CMWs who had a prior SARS-CoV-2 diagnosis was 9.3% (95% CI, 7.9%–11.0%). Only seven infections were ever severe, and only 1 was ever critical—an infection severity rate of 0.5% (95% CI, 0.2%–1.0%).

Conclusions

Six in every 10 CMWs in Qatar have been infected, suggestive of reaching the herd immunity threshold. Infection severity was low, with only 1 in every 200 infections progressing to be severe or critical. Only 1 in every 10 infections had been previously diagnosed, which is suggestive of mostly asymptomatic or mild infections.

Article activity feed

  1. SciScore for 10.1101/2020.11.24.20237719: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: A written informed consent was collected from all study participants.
    IRB: The study was approved by Hamad Medical Corporation (HMC) and Weill Cornell Medicine-Qatar Institutional Review Boards.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Study design and sampling: A national cross-sectional survey was conducted between July 26 and September 09, 2020 to assess anti-SARS-CoV-2 (antibody) positivity and SARS-CoV-2 polymerase chain reaction (PCR) positivity among CMWs in Qatar.
    anti-SARS-CoV-2
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    This study had limitations. While the study design was intended to be based on probability-based sampling of the total CMW population in Qatar, operational challenges and time constraints forced instead a systematic sampling of QRCS attendees supplemented with probability-based weights to generate an estimate that is representative of the wider CMW population. It was difficult to recruit participants in the small age-nationality strata (such as among younger persons for specific nationalities), and thus towards the end of the study all attendees in these strata (not only every 4th attendee) were approached to participate. Operational challenges made it also difficult to track and maintain consistent logs of the response rate by the nurses in these QRCS centers, thus an exact estimate of the response rate could not be ascertained, though it was estimated at >90% for antibody testing and at >70% for PCR testing. These limitations may have also introduced selection bias, such as biasing the assessed PCR positivity prevalence and infection severity rate towards higher values, as participants may have attended at the QRCS centers because of current-infection symptoms. The laboratory methods were based on high-quality and validated commercial platforms, such as the Roche platform used for the serological testing [18, 39], one of the best available and extensively used and investigated commercial platforms with a specificity ≥99.8% [18, 40] and a sensitivity ≥95% [7, 39]. However, t...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.